^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Gastroesophageal Junction Adenocarcinoma |
| Drug: | capecitabine (Thymidylate synthase inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
12/23/2020
Excerpt:
Gastroesophageal Junction Adenocarcinoma: Principles of systemic therapy…Other recommended regimens…Fluoropyrimidine (fluorouracil or capecitabine)
